- Catalog ingredients or strategy
- Hydroquinone-containing and hydroquinone-free possibilities
- Provider
- Agency
- Finished-product status
- Provider-described compounded prescription
- Source date
- October 8, 2026
What is being prescribed?
Agency describes the product around visible discoloration and lists possible actives and separate bases for hydroquinone-containing and hydroquinone-free formulas. That distinction is explicit on the provider page. The consultation should explain which preparation is being considered.[source]
What supports the claims?
As a compounded prescription, the finished product is not FDA-approved. The strength of an ingredient or a provider’s marketing comparison does not independently establish superior results from the exact formula. This review did not verify a head-to-head clinical trial against CoreAge Rx Spot On.[source]
The detail that changes the comparison
The reviewed listing displayed $110 for 18 grams with a 60-day supply description. Confirm the full current charges and care terms. A formula that changes over time may also raise practical questions about which supply is shipped and what instructions apply.[source]
Questions for the consultation
Ask about the diagnosis behind the discoloration, the planned treatment interval and how changes in the formula are explained. Unexpected pigment changes or irritation should be discussed with the prescribing professional. The review does not supply a hydroquinone treatment course.
Relevant alternatives
Spot On is a useful category alternative with a more specific listed ingredient combination. Align the formula before comparing quantity or price. The pigment-care questions are designed to make that consultation more concrete.
Your questions, answered
Does Dark Spot Rx always contain hydroquinone?
No. The provider describes hydroquinone-free possibilities. The product name identifies a family; the dispensing label identifies the individual preparation.
Was this cream tested by the publication?
No. This is a source-based review, without hands-on application, laboratory testing or independent medical review. Provider statements and broader ingredient evidence are identified separately.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- Agency — Dark Spot RxProduct page; not every personalized formula contains hydroquinone
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations